Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE IMMUNOGEN, INC.

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.878
Bid: 0.876
Ask: 0.88
Change: 0.002 (0.23%)
Spread: 0.004 (0.457%)
Open: 0.88
High: 0.88
Low: 0.874
Prev. Close: 0.876
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STATEMENT RE IMMUNOGEN, INC.

13 Feb 2024 07:00

RNS Number : 9464C
BioPharma Credit PLC
13 February 2024
 

BioPharma Credit PLC

13 February 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE ImmunoGen, Inc.

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 12 February 2024 by AbbVie Inc. ("AbbVie") regarding the completion of its acquisition of ImmunoGen, Inc. ("IMGN") (such acquisition, the "Transaction"). AbbVie and IMGN had previously announced the entering into of a definitive agreement regarding the Transaction on Thursday 30 November 2023.

 

The Company announced on 11 April 2023 an investment in a senior secured loan to IMGN of up to US$62.5 million in up to two tranches. The Company had previously funded the first tranche representing a US$37.5 million investment, which was prepaid upon the closing of the Transaction. The Company received US$50.6 million in total, including $13.1 million of accrued interest, additional consideration, and prepayment and make-whole fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRGPUUCPUPCUQW
12345678910
Date   Source Headline
7th Nov 20194:30 pmRNSHolding(s) in Company
7th Nov 20193:00 pmRNSDividend Declaration
4th Nov 20195:45 pmRNSHolding(s) in Company
22nd Oct 20194:26 pmRNSHolding(s) in Company
22nd Oct 20194:23 pmRNSHolding(s) in Company
21st Oct 20194:00 pmRNSNet Asset Value(s)
20th Sep 20194:00 pmRNSNet Asset Value(s)
16th Sep 201911:15 amRNSHolding(s) in Company
13th Sep 20197:00 amRNSNew Investment
11th Sep 20195:10 pmRNSUpdate on Investment
4th Sep 20197:00 amRNSHalf-year Report
21st Aug 20194:00 pmRNSNet Asset Value(s)
12th Aug 20197:00 amRNSNotice of Interim Results
7th Aug 20191:00 pmRNSReplacement: Dividend Declaration
2nd Aug 20194:00 pmRNSDividend Declaration
30th Jul 20197:00 amRNSUPDATE ON INVESTMENT
19th Jul 20194:00 pmRNSNet Asset Value(s)
11th Jul 20194:00 pmRNSDirector/PDMR Shareholding
25th Jun 20195:00 pmRNSHolding(s) in Company
21st Jun 20194:00 pmRNSNet Asset Value(s)
19th Jun 20196:12 pmRNSResult of AGM
29th May 20197:00 amRNSNew Investment
22nd May 20194:00 pmRNSNet Asset Value(s)
14th May 20194:00 pmRNSDividend Declaration
23rd Apr 20194:00 pmRNSNet Asset Value(s)
21st Mar 20194:00 pmRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
27th Feb 201910:40 amRNSNOTICE OF FULL YEAR RESULTS
21st Feb 20195:00 pmRNSDividend Declaration
21st Feb 20194:00 pmRNSNet Asset Value(s)
22nd Jan 20194:00 pmRNSNet Asset Value(s)
22nd Jan 20194:00 pmRNSSTATEMENT RE TESARO
15th Jan 201911:00 amRNSDirector/PDMR Shareholding
21st Dec 20184:00 pmRNSNet Asset Value(s)
6th Dec 20187:00 amRNSAppointment of Director
4th Dec 20187:00 amRNSSTATEMENT RE TESARO
3rd Dec 20182:45 pmRNSTotal Voting Rights
26th Nov 201810:45 amRNSDirector Declaration
21st Nov 20184:00 pmRNSNet Asset Value(s)
14th Nov 20183:00 pmRNSHolding(s) in Company
7th Nov 20182:30 pmRNSHolding(s) in Company
7th Nov 20182:30 pmRNSHolding(s) in Company
7th Nov 20182:30 pmRNSHolding(s) in Company
7th Nov 20182:30 pmRNSHolding(s) in Company
7th Nov 20181:15 pmRNSHolding(s) in Company
5th Nov 201811:15 amRNSTotal Voting Rights
1st Nov 20187:00 amRNSResults of Placing
29th Oct 20181:45 pmRNSTotal Voting Rights
29th Oct 20187:00 amRNSAdmission of Equity
24th Oct 20187:00 amRNSIncrease in Proposed Placing Size
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.